Synageva BioPharma

Synageva BioPharma

A biopharmaceutical company that develops and commercializes protein therapeutics for the treatment of rare diseases

No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.

No article has been written about this topic yet.
Be the first one to add some text.

Loading AI-assisted edit mode...

Timeline

April 15, 2009

Synageva BioPharma raises a $30,000,000 series F round from Tullis Health Investors.

Funding rounds

Funding round
Description
Funding round amount (USD)
Funding type
Funding round date
Investment
2 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Girlando Santos

Employee

Jason Semo

Employee

John j. Thomas

Employee

Maria Llorens Depner

Employee

Stefanie Ernst

Employee

Further reading

Title
Author
Link
Type
Date
+ Add new row

Documentaries, videos and podcasts

Title
Date
Link
+ Add new row

Companies

Company
CEO
Location
Products/Services
+ Add new row